Predictive Model of Chemotherapy-Induced Myelosuppression for Patients with Esophageal Cancer

Predictive Model of Chemotherapy-Induced Myelosuppression for Patients with Esophageal Cancer

Background The influential factors of chemotherapy-induced myelosuppression in esophageal cancer in central China are unclear. This study aimed to develop a model for prediction of incidence of myelosuppression during chemotherapy among patients with esophageal cancer. Methods In this retrospective...

Full description

Bibliographic Details
Main Authors:	Ziming Zheng, Qilin Zhang, Yong Han, Tingting Wu, Yu Zhang
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-09-01
Series:	Cancer Control
Online Access:	https://doi.org/10.1177/10732748221126929

Similar Items

Ginsenoside Rg3 for Chemotherapy-Induced Myelosuppression: A Meta-Analysis and Systematic Review
by: Linlin Pan, et al.
Published: (2020-05-01)

Comparison of Different Time Nutritional Intervention on Chemotherapy-induced Ⅳ Degree Myelosuppression in Cancer Patients
by: QI Xiaoguang, et al.
Published: (2018-01-01)

Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life
by: Epstein RS, et al.
Published: (2021-02-01)

Development of a Machine Learning-Based Prediction Model for Chemotherapy-Induced Myelosuppression in Children with Wilms’ Tumor
by: Mujie Li, et al.
Published: (2023-02-01)

A nomogram for predicting severe myelosuppression in small cell lung cancer patients following the first-line chemotherapy
by: Yaoyuan Li, et al.
Published: (2023-10-01)

Carbohydrates and ginsenosides in shenmai injection jointly improve hematopoietic function during chemotherapy-induced myelosuppression in mice
by: Shiyu Zhang, et al.
Published: (2022-11-01)

A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer
by: Kyemyung Park, et al.
Published: (2022-04-01)

Exosomal miR-122-5p is Related to the Degree of Myelosuppression Caused by Chemotherapy in Patients with Colorectal Cancer
by: Chen J, et al.
Published: (2021-11-01)

Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome
by: Lito E. Papanicolas, et al.
Published: (2021-05-01)

Predictors of Myelosuppression for Patients with Head and Neck Squamous Cell Carcinoma After Induction Chemotherapy
by: Wen-qing Chen, et al.
Published: (2024-01-01)

Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience
by: Shinya Tsuboi, et al.
Published: (2023-01-01)

Pharmacometabolomic prediction of individual differences of gastrointestinal toxicity complicating myelosuppression in rats induced by irinotecan
by: Yiqiao Gao, et al.
Published: (2019-01-01)

Correction to: Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience
by: Shinya Tsuboi, et al.
Published: (2023-04-01)

Zusanli (ST36) Acupoint Injection With Dexamethasone for Chemotherapy-Induced Myelosuppression: A Systematic Review and Meta-Analysis
by: Jiangfeng Chen, et al.
Published: (2021-07-01)

Lurasidone Induced Thrombocytopenia: Is it a Signal of Drug Induced Myelosuppression?
by: Mohammad Rafi, et al.
Published: (2018-03-01)

Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices
by: Lowell Hart, et al.
Published: (2023-04-01)

Studies of the effects and mechanisms of ginsenoside Re and Rk3 on myelosuppression induced by cyclophosphamide
by: Jiahong Han, et al.
Published: (2019-10-01)

Antibiotics Modulate Chemotherapy Efficacy in Patients with Esophageal Cancer
by: Wu C, et al.
Published: (2020-06-01)

The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials
by: Jingyue Qiu, et al.
Published: (2023-05-01)

Myelosuppression of Thrombocytes and Monocytes Is Associated with a Lack of Synergy between Chemotherapy and Anti-VEGF Treatment
by: Patrick Starlinger, et al.
Published: (2011-05-01)

POLYSACCHARIDES TUSSILAGOFARFARA L. REDUCE MYELOSUPPRESSION INDUCED BY CISPLATIN AND ETOPOSIDE
by: E. A. Safonova, et al.
Published: (2017-09-01)

Transcriptome Profiling Analysis Reveals the Potential Mechanisms of Three Bioactive Ingredients of Fufang E’jiao Jiang During Chemotherapy-Induced Myelosuppression in Mice
by: Xue Li, et al.
Published: (2018-06-01)

Factors Predicting Severe Myelosuppression and Its Influence on Fertility in Patients with Low-Risk Gestational Trophoblastic Neoplasia Receiving Single-Agent Methotrexate Chemotherapy
by: Tu X, et al.
Published: (2020-06-01)

The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial
by: Yajie Ji, et al.
Published: (2020-10-01)

The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma
by: Judith A. E. M. Zecha, et al.
Published: (2022-06-01)

Danggui Jixueteng decoction for the treatment of myelosuppression after chemotherapy: A combined metabolomics and network pharmacology analysis
by: Mingxin Guo, et al.
Published: (2024-02-01)

Efficacy of immunonutritional supplement after neoadjuvant chemotherapy in patients with esophageal cancer
by: Chao Luo, et al.
Published: (2022-03-01)

Quantitative CT analysis to predict esophageal fistula in patients with advanced esophageal cancer treated by chemotherapy or chemoradiotherapy
by: Yan-Jie Shi, et al.
Published: (2022-11-01)

P1348: C3G CONTROLS MEGAKARYOCYTE INFLUENCE ON MYELOID COMMITMENT OF HEMATOPOIETIC STEM CELLS UPON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION.
by: Óscar Herranz, et al.
Published: (2023-08-01)

Myelosuppression Rates with Administration of Nafcillin with and without Rifampin in Pediatric Patients
by: Jolly Kuriakose, et al.
Published: (2022-06-01)

Association of genetic variants in NUDT15 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease
by: Walker, GJ, et al.
Published: (2019)

Model‐based approach to identify predictors of paclitaxel‐induced myelosuppression in “real‐world” administration
by: Ahmed M. Salem, et al.
Published: (2023-07-01)

Editorial: Chemotherapy in esophageal cancer
by: Jiang Chen, et al.
Published: (2022-12-01)

Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide
by: He Zhang, et al.
Published: (2022-04-01)

Phosphate Metabolic Inhibition Contributes to Irradiation-Induced Myelosuppression through Dampening Hematopoietic Stem Cell Survival
by: Yiding Wu, et al.
Published: (2022-08-01)

Danggui Buxue Decoction, a Classical Formula of Traditional Chinese Medicine, Fails to Prevent Myelosuppression in Breast Cancer Patients Treated With Adjuvant Chemotherapy: A Prospective Study
by: Jin Hong MD, et al.
Published: (2017-09-01)

Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia.
by: Felix Jost, et al.
Published: (2019-01-01)

Cholesterol confers ferroptosis resistance onto myeloid-biased hematopoietic stem cells and prevents irradiation-induced myelosuppression
by: Chaonan Liu, et al.
Published: (2023-06-01)

Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer
by: Xiaoyuan Ma, et al.
Published: (2023-09-01)

Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study
by: Zhao-Yang Chen, et al.
Published: (2021-05-01)